
### [MONDO:0019050](http://purl.obolibrary.org/obo/MONDO_0019050)
**Label:** hemoglobinopathy

**Subclasses:** [MONDO:0016489](http://purl.obolibrary.org/obo/MONDO_0016489) (delta-beta-thalassemia), [MONDO:0016488](http://purl.obolibrary.org/obo/MONDO_0016488) (beta-thalassemia associated with another hemoglobin anomaly), [MONDO:0016243](http://purl.obolibrary.org/obo/MONDO_0016243) (hemoglobin E disease), [MONDO:0016242](http://purl.obolibrary.org/obo/MONDO_0016242) (hemoglobin c disease), [MONDO:0016487](http://purl.obolibrary.org/obo/MONDO_0016487) (beta-thalassemia intermedia), [MONDO:0018740](http://purl.obolibrary.org/obo/MONDO_0018740) (drug-induced methemoglobinemia), [MONDO:0016486](http://purl.obolibrary.org/obo/MONDO_0016486) (beta-thalassemia major), [MONDO:0009950](http://purl.obolibrary.org/obo/MONDO_0009950) (pyruvate kinase deficiency of red cells), [MONDO:0018022](http://purl.obolibrary.org/obo/MONDO_0018022) (hemoglobin Lepore-beta-thalassemia syndrome), [MONDO:0018023](http://purl.obolibrary.org/obo/MONDO_0018023) (hemoglobin M disease), [MONDO:0008545](http://purl.obolibrary.org/obo/MONDO_0008545) (thalassemia, beta+, silent Allele), [MONDO:0008789](http://purl.obolibrary.org/obo/MONDO_0008789) (anemia, nonspherocytic hemolytic, associated with abnormality of red cell membrane), [MONDO:0011399](http://purl.obolibrary.org/obo/MONDO_0011399) (alpha thalassemia), [MONDO:0010745](http://purl.obolibrary.org/obo/MONDO_0010745) (beta-thalassemia-X-linked thrombocytopenia syndrome), [MONDO:0018749](http://purl.obolibrary.org/obo/MONDO_0018749) (hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome), [MONDO:0011382](http://purl.obolibrary.org/obo/MONDO_0011382) (sickle cell anemia), [MONDO:0011381](http://purl.obolibrary.org/obo/MONDO_0011381) (dominant beta-thalassemia), [MONDO:0016513](http://purl.obolibrary.org/obo/MONDO_0016513) (alpha-thalassemia-related diseases), [MONDO:0016672](http://purl.obolibrary.org/obo/MONDO_0016672) (hereditary persistence of fetal hemoglobin-sickle cell disease syndrome), [MONDO:0016671](http://purl.obolibrary.org/obo/MONDO_0016671) (sickle cell-hemoglobin E disease syndrome), [MONDO:0016670](http://purl.obolibrary.org/obo/MONDO_0016670) (sickle cell-hemoglobin d disease syndrome), [MONDO:0000984](http://purl.obolibrary.org/obo/MONDO_0000984) (thalassemia), [MONDO:0001117](http://purl.obolibrary.org/obo/MONDO_0001117) (methemoglobinemia), [MONDO:0000105](http://purl.obolibrary.org/obo/MONDO_0000105) (anemia, nonspherocytic hemolytic), [MONDO:0020459](http://purl.obolibrary.org/obo/MONDO_0020459) (Unstable hemoglobin disease), [MONDO:0019537](http://purl.obolibrary.org/obo/MONDO_0019537) (hemoglobin d disease), [MONDO:0010480](http://purl.obolibrary.org/obo/MONDO_0010480) (anemia, nonspherocytic hemolytic, due to G6Pd deficiency), [MONDO:0018963](http://purl.obolibrary.org/obo/MONDO_0018963) (hereditary methemoglobinemia), [MONDO:0016667](http://purl.obolibrary.org/obo/MONDO_0016667) (sickle cell disease associated with an other hemoglobin anomaly), [MONDO:0017238](http://purl.obolibrary.org/obo/MONDO_0017238) (hemoglobinopathy Toms River), [MONDO:0013275](http://purl.obolibrary.org/obo/MONDO_0013275) (hemolytic anemia due to glucophosphate isomerase deficiency), [MONDO:0013517](http://purl.obolibrary.org/obo/MONDO_0013517) (beta-thalassemia HBB/LCRB), [MONDO:0016669](http://purl.obolibrary.org/obo/MONDO_0016669) (sickle cell-hemoglobin c disease syndrome), [MONDO:0013512](http://purl.obolibrary.org/obo/MONDO_0013512) (hemoglobin H disease), [MONDO:0016668](http://purl.obolibrary.org/obo/MONDO_0016668) (sickle cell-beta-thalassemia disease syndrome), [MONDO:0015579](http://purl.obolibrary.org/obo/MONDO_0015579) (Hb Bart's hydrops fetalis), [MONDO:0010328](http://purl.obolibrary.org/obo/MONDO_0010328) (alpha-thalassemia-myelodysplastic syndrome), [MONDO:0008790](http://purl.obolibrary.org/obo/MONDO_0008790) (anemia, nonspherocytic hemolytic, possibly due to defect 1N porphyrin metabolism), [MONDO:0017145](http://purl.obolibrary.org/obo/MONDO_0017145) (beta-thalassemia and related diseases), [MONDO:0017144](http://purl.obolibrary.org/obo/MONDO_0017144) (alpha-thalassemia and related diseases), [MONDO:0019402](http://purl.obolibrary.org/obo/MONDO_0019402) (beta thalassemia), [MONDO:0018750](http://purl.obolibrary.org/obo/MONDO_0018750) (class i glucose-6-phosphate dehydrogenase deficiency), [MONDO:0017146](http://purl.obolibrary.org/obo/MONDO_0017146) (sickle cell disease and related diseases), [MONDO:0016492](http://purl.obolibrary.org/obo/MONDO_0016492) (beta-thalassemia with other manifestations), [MONDO:0016491](http://purl.obolibrary.org/obo/MONDO_0016491) (hemoglobin E-beta-thalassemia syndrome), [MONDO:0007716](http://purl.obolibrary.org/obo/MONDO_0007716) (alpha thalassemia-intellectual disability syndrome type 1), [MONDO:0006506](http://purl.obolibrary.org/obo/MONDO_0006506) (congenital nonspherocytic hemolytic anemia), [MONDO:0016490](http://purl.obolibrary.org/obo/MONDO_0016490) (hemoglobin c-beta-thalassemia syndrome), [MONDO:0009604](http://purl.obolibrary.org/obo/MONDO_0009604) (methemoglobin reductase deficiency), [MONDO:0009605](http://purl.obolibrary.org/obo/MONDO_0009605) (methemoglobinemia type 4), [MONDO:0009606](http://purl.obolibrary.org/obo/MONDO_0009606) (methemoglobinemia due to deficiency of methemoglobin reductase), [MONDO:0010519](http://purl.obolibrary.org/obo/MONDO_0010519) (alpha thalassemia-X-linked intellectual disability syndrome), 

**Mapped go classes:** [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0015671](http://purl.obolibrary.org/obo/GO_0015671) (oxygen transport), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0045648](http://purl.obolibrary.org/obo/GO_0045648) (positive regulation of erythrocyte differentiation), [GO:0046185](http://purl.obolibrary.org/obo/GO_0046185) (aldehyde catabolic process), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0019242](http://purl.obolibrary.org/obo/GO_0019242) (methylglyoxal biosynthetic process), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0001707](http://purl.obolibrary.org/obo/GO_0001707) (mesoderm formation), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0017053](http://purl.obolibrary.org/obo/GO_0017053) (transcriptional repressor complex), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0016866](http://purl.obolibrary.org/obo/GO_0016866) (intramolecular transferase activity), [GO:0030492](http://purl.obolibrary.org/obo/GO_0030492) (hemoglobin binding), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:1904879](http://purl.obolibrary.org/obo/GO_1904879) (positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0097067](http://purl.obolibrary.org/obo/GO_0097067) (cellular response to thyroid hormone stimulus), [GO:0009408](http://purl.obolibrary.org/obo/GO_0009408) (response to heat), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0070742](http://purl.obolibrary.org/obo/GO_0070742) (C2H2 zinc finger domain binding), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0033198](http://purl.obolibrary.org/obo/GO_0033198) (response to ATP), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0048029](http://purl.obolibrary.org/obo/GO_0048029) (monosaccharide binding), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004768](http://purl.obolibrary.org/obo/GO_0004768) (stearoyl-CoA 9-desaturase activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0001816](http://purl.obolibrary.org/obo/GO_0001816) (cytokine production), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016208](http://purl.obolibrary.org/obo/GO_0016208) (AMP binding), [GO:0004345](http://purl.obolibrary.org/obo/GO_0004345) (glucose-6-phosphate dehydrogenase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0030502](http://purl.obolibrary.org/obo/GO_0030502) (negative regulation of bone mineralization), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0051287](http://purl.obolibrary.org/obo/GO_0051287) (NAD binding), [GO:0031838](http://purl.obolibrary.org/obo/GO_0031838) (haptoglobin-hemoglobin complex), [GO:0019825](http://purl.obolibrary.org/obo/GO_0019825) (oxygen binding), [GO:0033690](http://purl.obolibrary.org/obo/GO_0033690) (positive regulation of osteoblast proliferation), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0006094](http://purl.obolibrary.org/obo/GO_0006094) (gluconeogenesis), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0006098](http://purl.obolibrary.org/obo/GO_0006098) (pentose-phosphate shunt), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0006096](http://purl.obolibrary.org/obo/GO_0006096) (glycolytic process), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0004347](http://purl.obolibrary.org/obo/GO_0004347) (glucose-6-phosphate isomerase activity), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0001998](http://purl.obolibrary.org/obo/GO_0001998) (angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0010226](http://purl.obolibrary.org/obo/GO_0010226) (response to lithium ion), [GO:0046390](http://purl.obolibrary.org/obo/GO_0046390) (ribose phosphate biosynthetic process), [GO:0043209](http://purl.obolibrary.org/obo/GO_0043209) (myelin sheath), [GO:0006740](http://purl.obolibrary.org/obo/GO_0006740) (NADPH regeneration), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0006741](http://purl.obolibrary.org/obo/GO_0006741) (NADP biosynthetic process), [GO:0001047](http://purl.obolibrary.org/obo/GO_0001047) (core promoter binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0010559](http://purl.obolibrary.org/obo/GO_0010559) (regulation of glycoprotein biosynthetic process), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0097028](http://purl.obolibrary.org/obo/GO_0097028) (dendritic cell differentiation), [GO:0006739](http://purl.obolibrary.org/obo/GO_0006739) (NADP metabolic process), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0035854](http://purl.obolibrary.org/obo/GO_0035854) (eosinophil fate commitment), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0006754](http://purl.obolibrary.org/obo/GO_0006754) (ATP biosynthetic process), [GO:0002033](http://purl.obolibrary.org/obo/GO_0002033) (angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure), [GO:0045637](http://purl.obolibrary.org/obo/GO_0045637) (regulation of myeloid cell differentiation), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0005536](http://purl.obolibrary.org/obo/GO_0005536) (glucose binding), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0030955](http://purl.obolibrary.org/obo/GO_0030955) (potassium ion binding), [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0061052](http://purl.obolibrary.org/obo/GO_0061052) (negative regulation of cell growth involved in cardiac muscle cell development), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0034101](http://purl.obolibrary.org/obo/GO_0034101) (erythrocyte homeostasis), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0042542](http://purl.obolibrary.org/obo/GO_0042542) (response to hydrogen peroxide), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0051707](http://purl.obolibrary.org/obo/GO_0051707) (response to other organism), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0051024](http://purl.obolibrary.org/obo/GO_0051024) (positive regulation of immunoglobulin secretion), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0061620](http://purl.obolibrary.org/obo/GO_0061620) (glycolytic process through glucose-6-phosphate), [GO:0043531](http://purl.obolibrary.org/obo/GO_0043531) (ADP binding), [GO:0061621](http://purl.obolibrary.org/obo/GO_0061621) (canonical glycolysis), [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0004128](http://purl.obolibrary.org/obo/GO_0004128) (cytochrome-b5 reductase activity, acting on NAD(P)H), [GO:0051156](http://purl.obolibrary.org/obo/GO_0051156) (glucose 6-phosphate metabolic process), [GO:0048797](http://purl.obolibrary.org/obo/GO_0048797) (swim bladder formation), [GO:0031721](http://purl.obolibrary.org/obo/GO_0031721) (hemoglobin alpha binding), [GO:0031722](http://purl.obolibrary.org/obo/GO_0031722) (hemoglobin beta binding), [GO:0031720](http://purl.obolibrary.org/obo/GO_0031720) (haptoglobin binding), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0008301](http://purl.obolibrary.org/obo/GO_0008301) (DNA binding, bending), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0043154](http://purl.obolibrary.org/obo/GO_0043154) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0019322](http://purl.obolibrary.org/obo/GO_0019322) (pentose biosynthetic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping), [GO:0030222](http://purl.obolibrary.org/obo/GO_0030222) (eosinophil differentiation), [GO:0010734](http://purl.obolibrary.org/obo/GO_0010734) (negative regulation of protein glutathionylation), [GO:0060170](http://purl.obolibrary.org/obo/GO_0060170) (ciliary membrane), [GO:2000678](http://purl.obolibrary.org/obo/GO_2000678) (negative regulation of transcription regulatory region DNA binding), [GO:0030221](http://purl.obolibrary.org/obo/GO_0030221) (basophil differentiation), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0042866](http://purl.obolibrary.org/obo/GO_0042866) (pyruvate biosynthetic process), [GO:0043278](http://purl.obolibrary.org/obo/GO_0043278) (response to morphine), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005833](http://purl.obolibrary.org/obo/GO_0005833) (hemoglobin complex), [GO:0004743](http://purl.obolibrary.org/obo/GO_0004743) (pyruvate kinase activity), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0030219](http://purl.obolibrary.org/obo/GO_0030219) (megakaryocyte differentiation), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0032993](http://purl.obolibrary.org/obo/GO_0032993) (protein-DNA complex), [GO:0009051](http://purl.obolibrary.org/obo/GO_0009051) (pentose-phosphate shunt, oxidative branch), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0051591](http://purl.obolibrary.org/obo/GO_0051591) (response to cAMP), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0031090](http://purl.obolibrary.org/obo/GO_0031090) (organelle membrane), [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation), [GO:0004601](http://purl.obolibrary.org/obo/GO_0004601) (peroxidase activity), [GO:0032615](http://purl.obolibrary.org/obo/GO_0032615) (interleukin-12 production), [GO:0010725](http://purl.obolibrary.org/obo/GO_0010725) (regulation of primitive erythrocyte differentiation), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0010724](http://purl.obolibrary.org/obo/GO_0010724) (regulation of definitive erythrocyte differentiation), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0032613](http://purl.obolibrary.org/obo/GO_0032613) (interleukin-10 production), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 55.39%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) 51.41%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding) 51.41%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0043167](http://purl.obolibrary.org/obo/GO_0043167) (ion binding) 51.41%
- [GO:0043531](http://purl.obolibrary.org/obo/GO_0043531) (ADP binding) 50.70%
- [GO:0016208](http://purl.obolibrary.org/obo/GO_0016208) (AMP binding) 50.70%
- [GO:0005536](http://purl.obolibrary.org/obo/GO_0005536) (glucose binding) 50.70%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 50.70%
- [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity) 50.70%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0043169](http://purl.obolibrary.org/obo/GO_0043169) (cation binding) 50.70%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 50.70%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0043168](http://purl.obolibrary.org/obo/GO_0043168) (anion binding) and [GO:0043169](http://purl.obolibrary.org/obo/GO_0043169) (cation binding) 50.70%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0043169](http://purl.obolibrary.org/obo/GO_0043169) (cation binding) 50.70%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 50.70%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) 40.84%


